<DOC>
	<DOCNO>NCT02206711</DOCNO>
	<brief_summary>The purpose study ass pharmacokinetics ( PK ) , metabolism , rout extent elimination , safety tolerability single oral dose [ 14C ] BMS-955176 healthy male subject . There formal research hypothesis statistically test study .</brief_summary>
	<brief_title>Study Absorption , Metabolism , Route Elimination Novel Class Anti-HIV 1 Drugs ( BMS-955176 ) Humans .</brief_title>
	<detailed_description />
	<criteria>Healthy Male subject Ages 1850 year Body weight least 110 lb ( 50kg ) BMI 18 32 kg/m^2 nonsmoking Clinically significant diagnostic therapeutic radiation exposure within previous 12 month ( eg serial Xray CAT scan , barium meal ) . gastrointestinal disease include gastrointestinal surgery constipation irregular bowel movement</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>